Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Renal Dialysis Equipment Market

ID: MRFR/HC/41852-HCR
111 Pages
Rahul Gotadki
Last Updated: April 06, 2026
Renal Dialysis Equipment Market Research Report: Size, Share, Trend Analysis By Types of Dialysis (Hemodialysis, Peritoneal Dialysis, Continuous Renal Replacement Therapy), By Dialysis Equipment (Dialysis Machines, Dialyzers, Blood Tubing Sets, Dialysis Accessories), By End Use (In-Center Dialysis, Home Dialysis, Hospitals, Dialysis Clinics), By Patient Type (Adult Patients, Pediatric Patients, Geriatric Patients) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Type of Dialysis (USD Billion)
      1. 4.1.1 Hemodialysis
      2. 4.1.2 Peritoneal Dialysis
      3. 4.1.3 Continuous Renal Replacement Therapy
    2. 4.2 Healthcare, BY Dialysis Equipment (USD Billion)
      1. 4.2.1 Dialysis Machines
      2. 4.2.2 Dialyzers
      3. 4.2.3 Blood Tubing Sets
      4. 4.2.4 Dialysis Accessories
    3. 4.3 Healthcare, BY End-Use (USD Billion)
      1. 4.3.1 In-Center Dialysis
      2. 4.3.2 Home Dialysis
      3. 4.3.3 Hospitals
      4. 4.3.4 Dialysis Clinics
    4. 4.4 Healthcare, BY Patient Type (USD Billion)
      1. 4.4.1 Adult Patients
      2. 4.4.2 Pediatric Patients
      3. 4.4.3 Geriatric Patients
    5. 4.5 Healthcare, BY Region (USD Billion)
      1. 4.5.1 North America
        1. 4.5.1.1 US
        2. 4.5.1.2 Canada
      2. 4.5.2 Europe
        1. 4.5.2.1 Germany
        2. 4.5.2.2 UK
        3. 4.5.2.3 France
        4. 4.5.2.4 Russia
        5. 4.5.2.5 Italy
        6. 4.5.2.6 Spain
        7. 4.5.2.7 Rest of Europe
      3. 4.5.3 APAC
        1. 4.5.3.1 China
        2. 4.5.3.2 India
        3. 4.5.3.3 Japan
        4. 4.5.3.4 South Korea
        5. 4.5.3.5 Malaysia
        6. 4.5.3.6 Thailand
        7. 4.5.3.7 Indonesia
        8. 4.5.3.8 Rest of APAC
      4. 4.5.4 South America
        1. 4.5.4.1 Brazil
        2. 4.5.4.2 Mexico
        3. 4.5.4.3 Argentina
        4. 4.5.4.4 Rest of South America
      5. 4.5.5 MEA
        1. 4.5.5.1 GCC Countries
        2. 4.5.5.2 South Africa
        3. 4.5.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Fresenius Medical Care (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 DaVita Inc. (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Baxter International Inc. (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Nipro Corporation (JP)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Medtronic plc (IE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Asahi Kasei Medical Co., Ltd. (JP)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Dialysis Clinic, Inc. (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 KfH Kuratorium für Dialyse und Nierentransplantation e.V. (DE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY TYPE OF DIALYSIS
    4. 6.4 US MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    5. 6.5 US MARKET ANALYSIS BY END-USE
    6. 6.6 US MARKET ANALYSIS BY PATIENT TYPE
    7. 6.7 CANADA MARKET ANALYSIS BY TYPE OF DIALYSIS
    8. 6.8 CANADA MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    9. 6.9 CANADA MARKET ANALYSIS BY END-USE
    10. 6.10 CANADA MARKET ANALYSIS BY PATIENT TYPE
    11. 6.11 EUROPE MARKET ANALYSIS
    12. 6.12 GERMANY MARKET ANALYSIS BY TYPE OF DIALYSIS
    13. 6.13 GERMANY MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    14. 6.14 GERMANY MARKET ANALYSIS BY END-USE
    15. 6.15 GERMANY MARKET ANALYSIS BY PATIENT TYPE
    16. 6.16 UK MARKET ANALYSIS BY TYPE OF DIALYSIS
    17. 6.17 UK MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    18. 6.18 UK MARKET ANALYSIS BY END-USE
    19. 6.19 UK MARKET ANALYSIS BY PATIENT TYPE
    20. 6.20 FRANCE MARKET ANALYSIS BY TYPE OF DIALYSIS
    21. 6.21 FRANCE MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    22. 6.22 FRANCE MARKET ANALYSIS BY END-USE
    23. 6.23 FRANCE MARKET ANALYSIS BY PATIENT TYPE
    24. 6.24 RUSSIA MARKET ANALYSIS BY TYPE OF DIALYSIS
    25. 6.25 RUSSIA MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    26. 6.26 RUSSIA MARKET ANALYSIS BY END-USE
    27. 6.27 RUSSIA MARKET ANALYSIS BY PATIENT TYPE
    28. 6.28 ITALY MARKET ANALYSIS BY TYPE OF DIALYSIS
    29. 6.29 ITALY MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    30. 6.30 ITALY MARKET ANALYSIS BY END-USE
    31. 6.31 ITALY MARKET ANALYSIS BY PATIENT TYPE
    32. 6.32 SPAIN MARKET ANALYSIS BY TYPE OF DIALYSIS
    33. 6.33 SPAIN MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    34. 6.34 SPAIN MARKET ANALYSIS BY END-USE
    35. 6.35 SPAIN MARKET ANALYSIS BY PATIENT TYPE
    36. 6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE OF DIALYSIS
    37. 6.37 REST OF EUROPE MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    38. 6.38 REST OF EUROPE MARKET ANALYSIS BY END-USE
    39. 6.39 REST OF EUROPE MARKET ANALYSIS BY PATIENT TYPE
    40. 6.40 APAC MARKET ANALYSIS
    41. 6.41 CHINA MARKET ANALYSIS BY TYPE OF DIALYSIS
    42. 6.42 CHINA MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    43. 6.43 CHINA MARKET ANALYSIS BY END-USE
    44. 6.44 CHINA MARKET ANALYSIS BY PATIENT TYPE
    45. 6.45 INDIA MARKET ANALYSIS BY TYPE OF DIALYSIS
    46. 6.46 INDIA MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    47. 6.47 INDIA MARKET ANALYSIS BY END-USE
    48. 6.48 INDIA MARKET ANALYSIS BY PATIENT TYPE
    49. 6.49 JAPAN MARKET ANALYSIS BY TYPE OF DIALYSIS
    50. 6.50 JAPAN MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    51. 6.51 JAPAN MARKET ANALYSIS BY END-USE
    52. 6.52 JAPAN MARKET ANALYSIS BY PATIENT TYPE
    53. 6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE OF DIALYSIS
    54. 6.54 SOUTH KOREA MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    55. 6.55 SOUTH KOREA MARKET ANALYSIS BY END-USE
    56. 6.56 SOUTH KOREA MARKET ANALYSIS BY PATIENT TYPE
    57. 6.57 MALAYSIA MARKET ANALYSIS BY TYPE OF DIALYSIS
    58. 6.58 MALAYSIA MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    59. 6.59 MALAYSIA MARKET ANALYSIS BY END-USE
    60. 6.60 MALAYSIA MARKET ANALYSIS BY PATIENT TYPE
    61. 6.61 THAILAND MARKET ANALYSIS BY TYPE OF DIALYSIS
    62. 6.62 THAILAND MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    63. 6.63 THAILAND MARKET ANALYSIS BY END-USE
    64. 6.64 THAILAND MARKET ANALYSIS BY PATIENT TYPE
    65. 6.65 INDONESIA MARKET ANALYSIS BY TYPE OF DIALYSIS
    66. 6.66 INDONESIA MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    67. 6.67 INDONESIA MARKET ANALYSIS BY END-USE
    68. 6.68 INDONESIA MARKET ANALYSIS BY PATIENT TYPE
    69. 6.69 REST OF APAC MARKET ANALYSIS BY TYPE OF DIALYSIS
    70. 6.70 REST OF APAC MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    71. 6.71 REST OF APAC MARKET ANALYSIS BY END-USE
    72. 6.72 REST OF APAC MARKET ANALYSIS BY PATIENT TYPE
    73. 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. 6.74 BRAZIL MARKET ANALYSIS BY TYPE OF DIALYSIS
    75. 6.75 BRAZIL MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    76. 6.76 BRAZIL MARKET ANALYSIS BY END-USE
    77. 6.77 BRAZIL MARKET ANALYSIS BY PATIENT TYPE
    78. 6.78 MEXICO MARKET ANALYSIS BY TYPE OF DIALYSIS
    79. 6.79 MEXICO MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    80. 6.80 MEXICO MARKET ANALYSIS BY END-USE
    81. 6.81 MEXICO MARKET ANALYSIS BY PATIENT TYPE
    82. 6.82 ARGENTINA MARKET ANALYSIS BY TYPE OF DIALYSIS
    83. 6.83 ARGENTINA MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    84. 6.84 ARGENTINA MARKET ANALYSIS BY END-USE
    85. 6.85 ARGENTINA MARKET ANALYSIS BY PATIENT TYPE
    86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE OF DIALYSIS
    87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USE
    89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY PATIENT TYPE
    90. 6.90 MEA MARKET ANALYSIS
    91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE OF DIALYSIS
    92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY END-USE
    94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY PATIENT TYPE
    95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE OF DIALYSIS
    96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY END-USE
    98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY PATIENT TYPE
    99. 6.99 REST OF MEA MARKET ANALYSIS BY TYPE OF DIALYSIS
    100. 6.100 REST OF MEA MARKET ANALYSIS BY DIALYSIS EQUIPMENT
    101. 6.101 REST OF MEA MARKET ANALYSIS BY END-USE
    102. 6.102 REST OF MEA MARKET ANALYSIS BY PATIENT TYPE
    103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. 6.104 RESEARCH PROCESS OF MRFR
    105. 6.105 DRO ANALYSIS OF HEALTHCARE
    106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. 6.109 HEALTHCARE, BY TYPE OF DIALYSIS, 2024 (% SHARE)
    110. 6.110 HEALTHCARE, BY TYPE OF DIALYSIS, 2024 TO 2035 (USD Billion)
    111. 6.111 HEALTHCARE, BY DIALYSIS EQUIPMENT, 2024 (% SHARE)
    112. 6.112 HEALTHCARE, BY DIALYSIS EQUIPMENT, 2024 TO 2035 (USD Billion)
    113. 6.113 HEALTHCARE, BY END-USE, 2024 (% SHARE)
    114. 6.114 HEALTHCARE, BY END-USE, 2024 TO 2035 (USD Billion)
    115. 6.115 HEALTHCARE, BY PATIENT TYPE, 2024 (% SHARE)
    116. 6.116 HEALTHCARE, BY PATIENT TYPE, 2024 TO 2035 (USD Billion)
    117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.2.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.2.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.2.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.3.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.3.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.3.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.4.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.4.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.4.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.5.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.5.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.5.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.6.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.6.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.6.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.7.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.7.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.7.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.8.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.8.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.8.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.9.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.9.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.9.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.10.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.10.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.10.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.11.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.11.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.11.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.12.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.12.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.12.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.13.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.13.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.13.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.14.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.14.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.14.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.15.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.15.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.15.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.16.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.16.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.16.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.17.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.17.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.17.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.18.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.18.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.18.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.19.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.19.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.19.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.20.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.20.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.20.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.21.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.21.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.21.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.22.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.22.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.22.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.23.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.23.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.23.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.24.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.24.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.24.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.25.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.25.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.25.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.26.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.26.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.26.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.27.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.27.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.27.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.28.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.28.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.28.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.29.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.29.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.29.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY TYPE OF DIALYSIS, 2025-2035 (USD Billion)
      2. 7.30.2 BY DIALYSIS EQUIPMENT, 2025-2035 (USD Billion)
      3. 7.30.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.30.4 BY PATIENT TYPE, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Healthcare Market Segmentation

Healthcare By Type of Dialysis (USD Billion, 2025-2035)

  • Hemodialysis
  • Peritoneal Dialysis
  • Continuous Renal Replacement Therapy

Healthcare By Dialysis Equipment (USD Billion, 2025-2035)

  • Dialysis Machines
  • Dialyzers
  • Blood Tubing Sets
  • Dialysis Accessories

Healthcare By End-Use (USD Billion, 2025-2035)

  • In-Center Dialysis
  • Home Dialysis
  • Hospitals
  • Dialysis Clinics

Healthcare By Patient Type (USD Billion, 2025-2035)

  • Adult Patients
  • Pediatric Patients
  • Geriatric Patients